Cargando…
Outcomes of Critically Ill Lung Transplant Recipients with COVID-19
PURPOSE: Critically ill patients with COVID-19 are at high risk of morbidity and mortality. This risk may be even higher among lung transplant recipients (LTxRs) as they are immunosuppressed and typically older with multiple co-morbidities. The aim of this study was to characterize the outcomes of c...
Autores principales: | Razia, D., Padiyar, J., Schaheen, L., Grief, K., Walia, R., Tokman, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988755/ http://dx.doi.org/10.1016/j.healun.2022.01.1547 |
Ejemplares similares
-
(700) Vaccination with >2 Doses of Mrna Vaccines is Needed to Reduce Mortality Among Lung Transplant Recipients with Covid-19
por: Sindu, D., et al.
Publicado: (2023) -
(698) Covid-19 is Less Severe with the Omicron Variant Compared to Prior Variants and the Original Sars-Cov-2 Strain in Lung Transplant Recipients
por: Sindu, D., et al.
Publicado: (2023) -
COVID-19 Has a High Mortality Rate in Lung Transplant Recipients: A Large Single-Center Experience
por: Razia, D., et al.
Publicado: (2022) -
(349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients
por: Razia, D., et al.
Publicado: (2023) -
Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
por: Sindu, Devika, et al.
Publicado: (2023)